Task: Answer the MCQ question.
Question: Which drug exhibits a -4.706% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) COc1cccc(C(=O)Nc2ccccc2C(=O)N2CCCC2)c1
(b) CN1C(=O)/C(=C2/C=CC=CN2C)OC1=S
(c) CCN(CC)C(=O)c1ccc(COc2ccccc2Cl)cc1
(d) Cc1ccc(C(C(=O)NCc2ccco2)N(C(=O)CNC(=O)c2cccs2)c2ccccc2C)cc1
Answer: b. CN1C(=O)/C(=C2/C=CC=CN2C)OC1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1C(=O)/C(=C2/C=CC=CN2C)OC1=S
CN1C(=O)/C(=C2/C=CC=CN2C)OC1=S
(5E)-3-methyl-5-(1-methylpyridin-2-ylidene)-2-sulfanylidene-1,3-oxazolidin-4-one